Shaun M. Kirwan

Stable Dry Powder Formulation for Nasal Delivery of Anthrax Vaccine

Sheena H. Wang, Shaun M. Kirwan, Soman N. Abraham et al. · Journal of Pharmaceutical Sciences · 2011 · 94 citations · Full text

Vaccination, Mucosal Vaccination, Anthrax Vaccine +6

In Vitro and In Vivo Characterization of Anthrax Anti-Protective Antigen and Anti-Lethal Factor Monoclonal Antibodies after Passive Transfer in a Mouse Lethal Toxin Challenge Model To Define Correlates of Immunity

Herman F. Staats, S. Munir Alam, Richard M. Scearce et al. · Infection and Immunity · 2007 · 60 citations · Full text

Effective induction of protective systemic immunity with nasally administered vaccines adjuvanted with IL-1

William M. Gwinn, Shaun M. Kirwan, Sheena H. Wang et al. · Vaccine · 2010 · 37 citations

Vaccination, Effective Induction, Mucosal Vaccination +12

A comparison of non-toxin vaccine adjuvants for their ability to enhance the immunogenicity of nasally-administered anthrax recombinant protective antigen

William M. Gwinn, Brandi T. Johnson, Shaun M. Kirwan et al. · Vaccine · 2013 · 27 citations · Full text

Vaccinology, Vaccination, Cross-protection +9

A mast cell degranulation screening assay for the identification of novel mast cell activating agents

Herman F. Staats, Shaun M. Kirwan, Hae Woong Choi et al. · MedChemComm · 2012 · 24 citations · Full text

Mast Cell Disorder, Immunology, Mc Degranulation Assay +17